Showing results (1561-1570 of 1,823) with videos related to

Sort By:
Pageof 183
Transplantation and Cellular Therapy|May 16, 2022
Ideal Body Weight Is Useful For Predicting Neutrophil Engraftment and Platelet Recovery for Overweight and Obese Recipients in Single-Unit Cord Blood TransplantationYosuke Okada, Hideki Nakasone, Takaaki Konuma, et al.
Transplantation and Cellular Therapy|July 22, 2021
Allogeneic Blood or Marrow Transplantation with Nonmyeloablative Conditioning and High-Dose Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis for Secondary Central Nervous System LymphomaCole H Sterling, Hua-Ling Tsai, Matthias Holdhoff, et al.
Transplantation and Cellular Therapy|July 22, 2021
Hematopoietic Stem Cell Transplantation for Patients with Autosomal Recessive Complete INF-λ Receptor 2 Deficiency: Experience in OmanHanan F Nazir, Abdulhakim Al Rawas, Salem Al Tamemi, et al.
Transplantation and Cellular Therapy|May 17, 2022
Change in Patients' Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for LymphomaAnna Barata, Aasha I Hoogland, Anuhya Kommalapati, et al.
Transplantation and Cellular Therapy|May 18, 2022
Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia in the Modern EraEmily C Liang, Juliana Craig, Stefan Torelli, et al.
Transplantation and Cellular Therapy|May 19, 2022
Relationship of Oropharyngeal Colonization Microorganisms to Clinical Outcomes within 100 Days after Allogeneic Hematopoietic Stem Cell TransplantationJianrong Ge, Xiya Wei, Yanting Gu, et al.
Transplantation and Cellular Therapy|July 15, 2021
Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic MalignanciesXin Shelley Wang, Samer A Srour, Meagan Whisenant, et al.
Transplantation and Cellular Therapy|March 17, 2022
Myeloablative Versus Reduced-Intensity Conditioning With Fludarabine/Busulfan for Myelodysplastic Syndrome: A Propensity Score-Matched AnalysisShuhei Kurosawa, Yoshimitsu Shimomura, Hidehiro Itonaga, et al.
Transplantation and Cellular Therapy|March 17, 2022
The Clinical Significance of BCR-ABL1 Mutations in Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Cell TransplantationTakayoshi Tachibana, Takeshi Kondo, Naoyuki Uchida, et al.
Transplantation and Cellular Therapy|March 18, 2022
Improved NK Cell Recovery Following Use of PTCy or Treg Expanded Donors in Experimental MHC-Matched Allogeneic HSCTDietlinde Wolf, Henry Barreras, Sabrina N Copsel, et al.
Pageof 183